应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02565 派格生物医药-B
已收盘 07-29 16:08:27
15.340
-0.200
-1.29%
最高
15.780
最低
15.080
成交量
22.95万
今开
15.640
昨收
15.540
日振幅
4.50%
总市值
59.21亿
流通市值
42.82亿
总股本
3.86亿
成交额
354.65万
换手率
0.08%
流通股本
2.79亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
派格生物医药-B07月28日获主力加仓30.7万元
市场透视 · 07-28 08:15
派格生物医药-B07月28日获主力加仓30.7万元
派格生物医药-B07月24日获主力加仓198.1万元
市场透视 · 07-24
派格生物医药-B07月24日获主力加仓198.1万元
派格生物上市不足半年破发30% 流血上市背后的资本绝境
新浪证券 · 07-23
派格生物上市不足半年破发30% 流血上市背后的资本绝境
派格生物医药-B07月21日获主力加仓123.6万元
市场透视 · 07-21
派格生物医药-B07月21日获主力加仓123.6万元
派格生物医药-B07月16日获主力加仓117.8万元
市场透视 · 07-16
派格生物医药-B07月16日获主力加仓117.8万元
创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力
金吾财讯 · 07-16
创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力
“崩溃式”IPO,市场还愿意再相信派格生物吗?
医曜 · 07-15
“崩溃式”IPO,市场还愿意再相信派格生物吗?
派格生物医药-B07月14日获主力加仓81.5万元
市场透视 · 07-14
派格生物医药-B07月14日获主力加仓81.5万元
派格生物医药-B07月11日主力净流入88.5万元 散户资金抛售
市场透视 · 07-11
派格生物医药-B07月11日主力净流入88.5万元 散户资金抛售
派格生物医药-B07月09日主力净流出23.4万元 散户资金买入
市场透视 · 07-09
派格生物医药-B07月09日主力净流出23.4万元 散户资金买入
派格生物医药-B07月07日主力净流出82.1万元 散户资金买入
市场透视 · 07-07
派格生物医药-B07月07日主力净流出82.1万元 散户资金买入
2025年港股IPO半年报——专题一:千亿募资破局 A to H 新消费 创新药点燃市场
新浪证券 · 07-04
2025年港股IPO半年报——专题一:千亿募资破局 A to H 新消费 创新药点燃市场
派格生物医药-B06月27日主力净流入85.1万元 散户资金抛售
市场透视 · 06-27
派格生物医药-B06月27日主力净流入85.1万元 散户资金抛售
21专访|Pivotal bioVenture柳丹:创新药爆发的种子十年前就已埋下
21世纪经济报道 · 06-11
21专访|Pivotal bioVenture柳丹:创新药爆发的种子十年前就已埋下
派格生物医药-B06月10日主力净流出18.7万元 散户资金买入
市场透视 · 06-10
派格生物医药-B06月10日主力净流出18.7万元 散户资金买入
手回集团、派格生物破发直击 如何优势变胜势?
首财 · 06-09
手回集团、派格生物破发直击 如何优势变胜势?
派格生物上市冲动与骨感现实
新浪财经 · 06-09
派格生物上市冲动与骨感现实
派格生物医药-B(02565)将1.13亿股非上市股份转换为H股
智通财经 · 06-05
派格生物医药-B(02565)将1.13亿股非上市股份转换为H股
派格生物医药-B06月05日遭主力抛售16万元
市场透视 · 06-05
派格生物医药-B06月05日遭主力抛售16万元
近期国内融资|派格生物、先通医药、和美药业赴港上市
药菓 · 06-03
近期国内融资|派格生物、先通医药、和美药业赴港上市
加载更多
公司概况
公司名称:
派格生物医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
派格生物医药(苏州)有限公司是一家专注于创新药物开发的生物医药公司,2008年5月成立于苏州工业园区生物产业园(bioBay)。基于对慢病发病机制、慢病患者治疗需求以及慢病市场竞争的深刻理解,公司聚焦新作用机制、具有潜在优势的靶点,通过HECTORTM核心技术体系自主开发成药性高、疗效和安全性良好的药物分子,广泛覆盖2型糖尿病、非酒精性脂肪肝病、肥胖、高尿酸血症及痛风以及阿尔兹海默症等患者数量大、用药周期长的多种慢性疾病,并逐渐延伸到其他慢病领域,包括阿片类药物引起的便秘、先天性高胰岛素血症等。
发行价格:
--
{"stockData":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物医药-B","latestPrice":15.34,"timestamp":1753776507333,"preClose":15.54,"halted":0,"volume":229500,"delay":0,"floatShares":279164339,"shares":385955532,"eps":-0.8438175485245978,"marketStatus":"已收盘","change":-0.2,"latestTime":"07-29 16:08:27","open":15.64,"high":15.78,"low":15.08,"amount":3546470,"amplitude":0.045045,"askPrice":15.44,"askSize":2000,"bidPrice":15.34,"bidSize":3500,"shortable":0,"etf":0,"ttmEps":-0.8438175485245978,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753839000000},"marketStatusCode":5,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":15.54,"openAndCloseTimeList":[[1753752600000,1753761600000],[1753765200000,1753776000000]],"volumeRatio":0.444767,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02565","defaultTab":"news","newsList":[{"id":"2554383772","title":"派格生物医药-B07月28日获主力加仓30.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554383772","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554383772?lang=zh_cn&edition=full","pubTime":"2025-07-28 16:15","pubTimestamp":1753690523,"startTime":"0","endTime":"0","summary":"07月28日, 派格生物医药-B股价涨1.57%,报收15.54元,成交金额377.7万元,换手率0.09%,振幅2.75%,量比0.37。派格生物医药-B今日主力资金净流入30.7万元,上一交易日主力净流入79.0万元。该股近5个交易日上涨6.58%,主力资金累计净流入578.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1655.9万元,其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728164916a4675e1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728164916a4675e1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02565"],"gpt_icon":0},{"id":"2553200537","title":"派格生物医药-B07月24日获主力加仓198.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553200537","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553200537?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344945,"startTime":"0","endTime":"0","summary":"07月24日, 派格生物医药-B股价涨0.26%,报收15.48元,成交金额823.0万元,换手率0.19%,振幅2.07%,量比0.66。派格生物医药-B今日主力资金净流入198.1万元,上一交易日主力净流入160.6万元。该股近5个交易日上涨12.99%,主力资金累计净流入666.0万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1631.3万元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165913a6bf5150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165913a6bf5150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2553297203","title":"派格生物上市不足半年破发30% 流血上市背后的资本绝境","url":"https://stock-news.laohu8.com/highlight/detail?id=2553297203","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553297203?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:50","pubTimestamp":1753257017,"startTime":"0","endTime":"0","summary":"聚焦GLP-1赛道的创新药企派格生物在今年5月27日登陆港交所,首日即暴跌25.9%,一个月内股价蒸发43.2%,至今仍深陷破发30%的泥潭。当资本市场为GLP-1狂欢时,派格生物却上演了一场惊心动魄的“资本大逃杀”。牌桌上的生死赌局尽管艰难上市,派格生物仍深陷资本困局。当资本市场给予GLP-1概念股超高溢价时,派格生物11港元的股价与破发30%的K线图形成刺眼对比——市场在用脚投票质疑其商业化前景。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072315505297b206c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072315505297b206c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":1},{"id":"2553847466","title":"派格生物医药-B07月21日获主力加仓123.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553847466","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553847466?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:15","pubTimestamp":1753085720,"startTime":"0","endTime":"0","summary":"07月21日, 派格生物医药-B股价涨7.21%,报收14.58元,成交金额1389.3万元,换手率0.35%,振幅8.09%,量比0.92。派格生物医药-B今日主力资金净流入123.6万元,连续7日净流入,上一交易日主力净流入73.8万元。该股近5个交易日上涨29.95%,主力资金累计净流入877.9万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1162.8万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165027a458f97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721165027a458f97c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02565"],"gpt_icon":0},{"id":"2552812140","title":"派格生物医药-B07月16日获主力加仓117.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552812140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552812140?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:15","pubTimestamp":1752653750,"startTime":"0","endTime":"0","summary":"07月16日, 派格生物医药-B股价涨8.67%,报收13.04元,成交金额2026.8万元,换手率0.56%,振幅14.83%,量比2.79。派格生物医药-B今日主力资金净流入117.8万元,连续4日净流入,上一交易日主力净流入253.0万元。该股近5个交易日上涨27.59%,主力资金累计净流入540.7万元;近20日主力资金累计净流入632.2万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170744a44e54ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716170744a44e54ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2551124121","title":"创新药概念走势向好 复宏汉霖涨9.72% 机构指板块估值仍具吸引力","url":"https://stock-news.laohu8.com/highlight/detail?id=2551124121","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551124121?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:41","pubTimestamp":1752644466,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念走势向好,派格生物医药 涨10.83%,复宏汉霖涨9.72%,康方生物涨7.13%,亚盛医药涨4.25%,诺诚健华涨3.5%。对于创新药出海演变方向,该机构观察以下趋势:1)行业进一步衍生出了NewCo等新型交易模式;2)ADC赛道交易兴趣度最高,双抗/多抗、小核酸/mRNA等前沿技术领域亦存在较多机会。基于当前国产创新药资产储备丰富且交易性价比仍显着、MNC存在专利补缺需求、海外投融资边际改善,该机构认为2H25-2026年出海交易热度仍将延续。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716135524a6acadc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716135524a6acadc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","09926","06855","BK1161","09969","02696","02565"],"gpt_icon":0},{"id":"2551190509","title":"“崩溃式”IPO,市场还愿意再相信派格生物吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2551190509","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551190509?lang=zh_cn&edition=full","pubTime":"2025-07-16 07:28","pubTimestamp":1752622104,"startTime":"0","endTime":"0","summary":"同时,派格生物本次IPO并没有绿鞋机制,进一步增加了股价剧烈波动的风险。正是乘着这股“创新药”东风,派格生物迅速完成了IPO上市,虽然去掉发行成本后,派格生物的净融资额仅为2.32亿港元,但这却足以让派格生物喘一口气了。02被“耽搁”的三年以结果看,派格生物借助IPO重新活过来了。在等待港股IPO时机的三年时间中,派格生物为了活下去,主动缩减了研发开支。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716073100a44d3a0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716073100a44d3a0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2551715900","title":"派格生物医药-B07月14日获主力加仓81.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551715900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551715900?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:15","pubTimestamp":1752480914,"startTime":"0","endTime":"0","summary":"07月14日, 派格生物医药-B股价涨2.75%,报收11.22元,成交金额576.1万元,换手率0.19%,振幅2.93%,量比1.38。派格生物医药-B今日主力资金净流入81.5万元,上一交易日主力净流入88.5万元。该股近5个交易日上涨6.65%,主力资金累计净流入170.6万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入259.9万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714165504a6a84f6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714165504a6a84f6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2550580936","title":"派格生物医药-B07月11日主力净流入88.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2550580936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550580936?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:15","pubTimestamp":1752221759,"startTime":"0","endTime":"0","summary":"07月11日, 派格生物医药-B股价涨5.41%,报收10.92元,成交金额469.0万元,换手率0.16%,振幅5.98%,量比0.88。派格生物医药-B今日主力资金净流入88.5万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.67%,主力资金累计净流入7.0万元;近20日主力资金累计净流入178.5万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711170915a6a37331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711170915a6a37331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2550638444","title":"派格生物医药-B07月09日主力净流出23.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550638444?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:15","pubTimestamp":1752048950,"startTime":"0","endTime":"0","summary":"07月09日, 派格生物医药-B股价跌0.39%,报收10.22元,成交金额187.6万元,换手率0.07%,振幅3.90%,量比0.31。派格生物医药-B今日主力资金净流出23.4万元,上一交易日主力净流入24.0万元。该股近5个交易日下跌2.29%,主力资金累计净流入50.0万元;近20日主力资金累计净流入46.4万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170329a69f0b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170329a69f0b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2549580062","title":"派格生物医药-B07月07日主力净流出82.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2549580062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549580062?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:15","pubTimestamp":1751876106,"startTime":"0","endTime":"0","summary":"07月07日, 派格生物医药-B股价跌6.24%,报收10.52元,成交金额762.7万元,换手率0.26%,振幅9.80%,量比1.10。派格生物医药-B今日主力资金净流出82.1万元,上一交易日主力净流入83.5万元。该股近5个交易日上涨5.41%,主力资金累计净流入29.2万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入27.2万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707164851a43b6fac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707164851a43b6fac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2548151360","title":"2025年港股IPO半年报——专题一:千亿募资破局 A to H 新消费 创新药点燃市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2548151360","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548151360?lang=zh_cn&edition=full","pubTime":"2025-07-04 18:26","pubTimestamp":1751624760,"startTime":"0","endTime":"0","summary":"2025年上半年,共7家A股公司完成港股IPO,合计募资超770亿港元,占IPO总额的72%,直接推升港股IPO募资额复苏。展望2025年下半年,将有数家A股公司登陆港交所,预计募资规模也将比肩上半年A to H募资额水平,进一步巩固大盘股主导地位。工业材料等板块IPO颓势 募资认购收益全面遇冷在A to H、消费、医疗医药等新经济赛道的狂欢图景中,工业、材料、信息技术、金融板块尽显颓势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704182723a72eaafe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704182723a72eaafe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603288","02565","02617","02619","HSCEI","06978","600276","HSTECH","BK1574","BK1161"],"gpt_icon":1},{"id":"2546719687","title":"派格生物医药-B06月27日主力净流入85.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2546719687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546719687?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:15","pubTimestamp":1751012152,"startTime":"0","endTime":"0","summary":"06月27日, 派格生物医药-B股价涨11.76%,报收9.98元,成交金额1085.0万元,换手率0.40%,振幅13.77%,量比5.57。派格生物医药-B今日主力资金净流入85.1万元,上一交易日主力净流出0万元。该股近5个交易日上涨10.38%,主力资金累计净流入85.1万元;近20日主力资金累计净流出78.3万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627173321a7208e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627173321a7208e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2542237523","title":"21专访|Pivotal bioVenture柳丹:创新药爆发的种子十年前就已埋下","url":"https://stock-news.laohu8.com/highlight/detail?id=2542237523","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542237523?lang=zh_cn&edition=full","pubTime":"2025-06-11 11:25","pubTimestamp":1749612303,"startTime":"0","endTime":"0","summary":"近日,Pivotal bioVenture管理合伙人柳丹博士在接受21世纪经济报道专访时说。2024年初,柳丹加入专注于生命科学投资的全球知名机构Pivotal bioVenture Partners,担任其中国区管理合伙人,同时进入投资委员会,全面领导中国区生命科学投资团队并管理运营业务。“Pivotal bioVenture侧重于跨境交易的促成,赋能中国创新药企业走向全球,满足日益增长的全球市场需求。”Pivotal bioVenture通过专业投资人和专家库,对项目进行投资判断。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611114720977a4dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611114720977a4dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","01093","02565","02142","688046","BK0216","01530","02629","159992","600276"],"gpt_icon":0},{"id":"2542689318","title":"派格生物医药-B06月10日主力净流出18.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2542689318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542689318?lang=zh_cn&edition=full","pubTime":"2025-06-10 16:15","pubTimestamp":1749543357,"startTime":"0","endTime":"0","summary":"06月10日, 派格生物医药-B股价跌3.77%,报收9.20元,成交金额576.2万元,换手率0.22%,振幅4.81%,量比1.35。派格生物医药-B今日主力资金净流出18.7万元,上一交易日主力净流出0万元。该股近5个交易日下跌5.15%,主力资金累计净流出74.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出300.6万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610174650a701eebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610174650a701eebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2542833365","title":"手回集团、派格生物破发直击 如何优势变胜势?","url":"https://stock-news.laohu8.com/highlight/detail?id=2542833365","media":"首财","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542833365?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:00","pubTimestamp":1749477600,"startTime":"0","endTime":"0","summary":"发行价15.6港元,上市首日便遇破发、大跌25.9%收于11.56港元。一个是国内第二大线上保险中介,一个是年内第五家未盈利生物科技上市公司,手回集团、派格生物可谓被寄予厚望。据招股书披露,手回集团首年保单佣金率从2022年的34.8%下滑至2024年的26.2%。根据相关协议,部分投资者的撤资权在手回集团首次提交上市申请时暂停,直至2025年9月30日或首次提交申请后的18个月。背负考题的,还有派格生物。招股书显示,2023年9月,派格生物该产品用","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609221153a4a08605&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609221153a4a08605&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","02621"],"gpt_icon":1},{"id":"2542541800","title":"派格生物上市冲动与骨感现实","url":"https://stock-news.laohu8.com/highlight/detail?id=2542541800","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542541800?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:20","pubTimestamp":1749460808,"startTime":"0","endTime":"0","summary":"5月27日,慢性病创新疗法研发公司派格生物在港交所上市。核心产品布局商业化尽管当前仍未产生产品商业化收入,但派格生物的核心产品距离获批上市仅有一步之遥。招股书披露,2024年9月,派格生物已与国内一家医药公司达成了在中国大陆地区的商业化合作。此阶段,派格生物将直面与多款同类药物或相同适应症下多种药物的角逐。早在2021年,派格生物就曾向科创板提交上市申请,此后也已对上交所的两轮意见作出回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609172326a4a0212c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609172326a4a0212c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","02565","BK1583","03347"],"gpt_icon":1},{"id":"2541404277","title":"派格生物医药-B(02565)将1.13亿股非上市股份转换为H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2541404277","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541404277?lang=zh_cn&edition=full","pubTime":"2025-06-05 16:38","pubTimestamp":1749112725,"startTime":"0","endTime":"0","summary":"智通财经APP讯,派格生物医药-B(02565)发布公告,于2025年6月5日将1.13亿股非上市股份转换为1.13亿股H股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1301667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","02565","399441"],"gpt_icon":0},{"id":"2541263460","title":"派格生物医药-B06月05日遭主力抛售16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541263460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541263460?lang=zh_cn&edition=full","pubTime":"2025-06-05 16:15","pubTimestamp":1749111346,"startTime":"0","endTime":"0","summary":"06月05日, 派格生物医药-B股价跌3.53%,报收9.84元,成交金额320.1万元,换手率0.11%,振幅4.71%,量比0.38。派格生物医药-B今日主力资金净流出16万元,上一交易日主力净流出19.9万元。该股近5个交易日下跌9.23%,主力资金累计净流出56.4万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出262.0万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605173140a49b2fa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605173140a49b2fa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565"],"gpt_icon":0},{"id":"2540173773","title":"近期国内融资|派格生物、先通医药、和美药业赴港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2540173773","media":"药菓","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540173773?lang=zh_cn&edition=full","pubTime":"2025-06-03 18:00","pubTimestamp":1748944826,"startTime":"0","endTime":"0","summary":"主要应用于在神经、心血管、肿瘤三大疾病领域,先通医药已实现全面布局,并拥有多款精准诊断和靶向治疗放射性药物研发管线。舜景医药创立于2018年,是一家创新驱动型生物医药技术公司,致力于原创性抗体药物的发现、开发以及商业化。和美药业已开发七个小分子候选药物,其中四种候选药物处于II期、 III期临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603180612a6f872d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"a6ebb226f01ab1197d003ac8f442408e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603180612a6f872d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","02565","BK1515","BK1574"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.pegbio.com","stockEarnings":[{"period":"1week","weight":0.0658},{"period":"1month","weight":0.5571},{"period":"3month","weight":-0.0038},{"period":"ytd","weight":-0.0038}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.2639},{"period":"1year","weight":0.5018},{"period":"ytd","weight":0.2743}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"派格生物医药(苏州)有限公司是一家专注于创新药物开发的生物医药公司,2008年5月成立于苏州工业园区生物产业园(bioBay)。基于对慢病发病机制、慢病患者治疗需求以及慢病市场竞争的深刻理解,公司聚焦新作用机制、具有潜在优势的靶点,通过HECTORTM核心技术体系自主开发成药性高、疗效和安全性良好的药物分子,广泛覆盖2型糖尿病、非酒精性脂肪肝病、肥胖、高尿酸血症及痛风以及阿尔兹海默症等患者数量大、用药周期长的多种慢性疾病,并逐渐延伸到其他慢病领域,包括阿片类药物引起的便秘、先天性高胰岛素血症等。","exchange":"SEHK","name":"派格生物医药-B","nameEN":"PEGBIO CO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"派格生物医药-B(02565)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供派格生物医药-B(02565)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"派格生物医药-B,02565,派格生物医药-B股票,派格生物医药-B股票老虎,派格生物医药-B股票老虎国际,派格生物医药-B行情,派格生物医药-B股票行情,派格生物医药-B股价,派格生物医药-B股市,派格生物医药-B股票价格,派格生物医药-B股票交易,派格生物医药-B股票购买,派格生物医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"派格生物医药-B(02565)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供派格生物医药-B(02565)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}